BT CLINICAL COMPUTING: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BT CLINICAL COMPUTING
Largest movements
- Intangible fixed assets -€64,393
down €64,393 (-42.7%), from €150,666 to €86,272
- Cash +€21,398
up €21,398 (+199%), from €10,763 to €32,161
mainly Depreciation (+€98,912) and Trade debts (+€17,045)
- Profit (loss) carried forward -€60,802
down €60,802 (-8.5%), from -€712,205 to -€773,006
- Trade debts +€17,045
up €17,045 (+873%), from €1,953 to €18,998
- Tax, wage and social debts +€4,479
new in 2025: €4,479
- Debts after one year -€4,000
down €4,000 (-1.1%), from €366,395 to €362,395
- Other debts -€3,356
no longer reported in 2025 (was €3,356)
- Gross operating margin +€46,717
up €46,717, from -€8,388 to €38,329
- Financial charges -€883
down €883 (-94.5%), from €934 to €51
- Other operating charges -€772
down €772 (-82.1%), from €940 to €168
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €162,149 | €118,871 | -€43,278 | -26.7% |
| Fixed assets | 21/28 | €150,666 | €86,272 | -€64,393 | -42.7% |
| Intangible fixed assets | 21 | €150,666 | €86,272 | -€64,393 | -42.7% |
| Current assets | 29/58 | €11,483 | €32,598 | +€21,115 | +184% |
| Amounts receivable within one year | 40/41 | €329 | €49 | -€280 | -85.0% |
| Trade receivables | 40 | - | €49 | +€49 | |
| Other amounts receivable | 41 | €329 | - | -€329 | |
| Cash at bank and in hand | 54/58 | €10,763 | €32,161 | +€21,398 | +199% |
| Deferred charges and accrued income | 490/1 | €391 | €389 | -€2 | -0.6% |
| Total equity and liabilities | 10/49 | €162,149 | €118,871 | -€43,278 | -26.7% |
| Equity | 10/15 | -€209,555 | -€270,356 | -€60,802 | -29.0% |
| Contributions | 10/11 | €502,650 | €502,650 | = | 0.0% |
| Capital | 10 | €502,650 | €502,650 | = | 0.0% |
| Issued capital | 100 | €502,650 | €502,650 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€712,205 | -€773,006 | -€60,802 | -8.5% |
| Amounts payable | 17/49 | €371,703 | €389,227 | +€17,524 | +4.7% |
| Amounts payable after more than one year | 17 | €366,395 | €362,395 | -€4,000 | -1.1% |
| Financial debts | 170/4 | €366,395 | €362,395 | -€4,000 | -1.1% |
| Amounts payable within one year | 42/48 | €5,308 | €23,477 | +€18,168 | +342% |
| Trade debts | 44 | €1,953 | €18,998 | +€17,045 | +873% |
| Suppliers | 440/4 | €1,953 | €18,998 | +€17,045 | +873% |
| Taxes, remuneration and social security | 45 | - | €4,479 | +€4,479 | |
| Taxes | 450/3 | - | €4,479 | +€4,479 | |
| Other amounts payable | 47/48 | €3,356 | - | -€3,356 | |
| Accrued charges and deferred income | 492/3 | - | €3,356 | +€3,356 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €99,221 | €98,912 | -€310 | -0.3% |
| Other operating charges | 640/8 | €940 | €168 | -€772 | -82.1% |
| Gross operating margin | 9900 | -€8,388 | €38,329 | +€46,717 | |
| Operating profit (loss) | 9901 | -€108,549 | -€60,751 | +€47,799 | +44.0% |
| Financial charges | 65/66B | €934 | €51 | -€883 | -94.5% |
| Recurring financial charges | 65 | €934 | €51 | -€883 | -94.5% |
| Profit (loss) for the period before taxes | 9903 | -€109,483 | -€60,802 | +€48,681 | +44.5% |
| Profit (loss) for the period | 9904 | -€109,483 | -€60,802 | +€48,681 | +44.5% |
| Profit (loss) for the period to be appropriated | 9905 | -€109,483 | -€60,802 | +€48,681 | +44.5% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.